Cementos Bio (Chile) Today
| CEMENTOS | CLP 1,303 3.00 0.23% |
Performance15 of 100
| Odds Of DistressLess than 9
|
Cementos Bio is selling at 1303.00 as of the 24th of November 2024; that is 0.23 percent increase since the beginning of the trading day. The stock's open price was 1300.0. Cementos Bio has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Cementos Bio B are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of November 2023 and ending today, the 24th of November 2024. Click here to learn more.
Cementos Bio Bio S.A. manufactures and sells cement in Chile and internationally. The company was founded in 1957 and is based in Providencia, Chile. CEMENTOS BIO is traded on Commodity Exchange in Exotistan. The company has 264.22 M outstanding shares. More on Cementos Bio B
Moving against Cementos Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cementos Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cementos Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cementos Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Building Materials, Basic Materials (View all Sectors) |
Cementos Bio B (CEMENTOS) is traded on Chilean Stock Exchange in Chile and employs 1,255 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 171.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cementos Bio's market, we take the total number of its shares issued and multiply it by Cementos Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cementos Bio B operates under Basic Materials sector and is part of Building Materials industry. The entity has 264.22 M outstanding shares.
Cementos Bio B has accumulated about 31.62 B in cash with 25.84 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 119.65.
Check Cementos Bio Probability Of Bankruptcy
Ownership AllocationCementos Bio holds a total of 264.22 Million outstanding shares. Cementos Bio B shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.46 percent of Cementos Bio B outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cementos Ownership Details
Cementos Bio B Risk Profiles
Although Cementos Bio's alpha and beta are two of the key measurements used to evaluate Cementos Bio's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.83 | |||
| Standard Deviation | 10.64 | |||
| Variance | 113.18 | |||
| Risk Adjusted Performance | 0.1175 |
Cementos Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cementos Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Cementos Bio Corporate Management
Elected by the shareholders, the Cementos Bio's board of directors comprises two types of representatives: Cementos Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cementos. The board's role is to monitor Cementos Bio's management team and ensure that shareholders' interests are well served. Cementos Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cementos Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edwin Romero | Ma Resource | Profile | |
| Francisco Zenteno | Corp Officer | Profile | |
| Ulysses Gonzlez | Ma Cal | Profile | |
| Enrique Hirmas | G Mang | Profile | |
| Ramn Portilla | Ma Devel | Profile | |
| Sebastin Neumann | Mang Matters | Profile |
Other Information on Investing in Cementos Stock
Cementos Bio financial ratios help investors to determine whether Cementos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cementos with respect to the benefits of owning Cementos Bio security.